Stock Market News & Analysis
stocks
Overvalued ASX pharma play hits FDA speedbump
We think a delay rather than an outright rejection for this company’s product is the likelier outcome, but the shares still look expensive.
stocks
Going into earnings, is Meta stock a buy, a sell, or fairly valued?
Watching AI monetization, Reels profitability, and Reality Labs spending, here’s what we think of Meta stock.
stocks
Alphabet earnings: Solid results as AI monetization continues to improve
We continue to view the stock as materially undervalued.
stocks
The most hated company on the ASX 200 right now
Down more than 70% in the last year is this share a bargain?
stocks
10 best US dividend aristocrats to buy now
These undervalued stocks with wide and narrow moats have increased their dividends for 25 consecutive years or more.
stocks
ASX healthcare leader continues to prove the doubters wrong
Niche play with more growth potential than many investors give it credit for.
stocks
Going into earnings, is Apple stock a buy, a sell, or fairly valued?
Watching iPhone revenue, services growth, and potential tariff impact, here’s what we think of Apple stock.
stocks
Cheap ASX energy firm’s big growth projects are on track
Markets seem overly bearish on this ASX oil and gas heavyweight, which appears to have overlooked secular tailwinds in its favour.
stocks
This cheap ASX miner can weather the storm in lithium
We cut our near-term forecast for lithium prices but remain optimistic regarding a longer-term recovery. This moated player looks well placed to benefit.
of 233
Viewing 1 to 16 of 3713